Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients
Conditions
Gastroenteropancreatic Neuroendocrine Tumor
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
AZ Klina, Brasschaat, Antwerp, Belgium
Contact: Study coordinator (Wim Demey)AZ Rivierenland, Rumst, Antwerp, Belgium
Ghent University Hospital, Ghent, East Flanders, Belgium
VITAZ, Sint-Niklaas, East-Flanders, Belgium
Contact: Study coordinator (Willem Lybaert)University Hospital Leuven, Leuven, Flemish Brabant, Belgium
Contact: Study coordinator (Chris Verslype)Grand Hôpital de Charleroi, Charleroi, Hainaut, Belgium
AZ Monica, Antwerp, Belgium
Contact: Study coordinator (Luc Poelmans)GZA, Antwerp, Belgium
Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium
Cliniques Universitaires Saint-Luc, Brussels, Belgium
Contact: Study coordinator (Ivan Borbath)H.U.B., Brussels, Belgium
Antwerp University Hospital, Edegem, Belgium
Centre Hospitalier Universitaire Sart Tilman, Liège, Belgium
Rijnstate, Arnhem, Gelderland, Netherlands
Contact: Study coordinator (Theo Van Voorthuizen)Maastricht UMC+, Maastricht, Limburg, Netherlands
Contact: Study coordinator (Loes Latten-Jansen)Maxima Medisch Centrum, Eindhoven, North Brabant, Netherlands
Amsterdam UMC, Amsterdam, North Holland, Netherlands
UMC Groningen, Groningen, Netherlands
Contact: Study coordinator (Annemiek Walenkamp)Erasmus MC, Rotterdam, Netherlands
Contact: Study coordinator (Hans Hofland)
Study leads
Marc Peeters, MD
Principal Investigator
University Hospital, Antwerp